StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
CBT

Cabot Corporation

CBT NYSE Miscellaneous Chemical Products EDGAR ↗
$77.76
-0.69 -0.88%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
$4.01B
Revenue (TTM) ⓘ
$3.63B
Net income (TTM) ⓘ
$190M
EPS (TTM) ⓘ
$3.56
P/E ratio ⓘ
21.8
Dividend yield ⓘ
2.34%
Free cash flow ⓘ
$391M
Cash ⓘ
$250M
Total assets ⓘ
$3.98B
Gross margin ⓘ
22.7%
52-week range ⓘ
$58.33 – $94.53

AI briefing

from the latest 10-K, 10-Q and 8-K events

Cabot Corporation is a global specialty chemicals and performance materials company operating through Reinforcement Materials and Performance Chemicals segments.

What they do

Cabot manufactures reinforcing carbons for tires and industrial products, as well as specialty carbons, compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel. It operates in over 20 countries with two reportable segments: Reinforcement Materials and Performance Chemicals.

Revenue drivers

  • Reinforcement Materials — Sells reinforcing carbons and E2C composites to tire and industrial product manufacturers; revenue driven by global volumes, pricing, and product mix.
  • Performance Chemicals — Includes specialty carbons, compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel; growth driven by demand in electronics, electric vehicles, and battery energy storage.
  • Battery Materials — A product line within Performance Chemicals; expanding global conductive additive capacity to support EV and battery storage demand, targeting ~$40 million EBITDA in fiscal 2026.

Recent performance

In Q3 fiscal 2026 (quarter ended June 30, 2026), net sales were $982 million, up from $923 million a year ago, but net income attributable to Cabot fell to $6 million ($0.12 EPS) from $101 million ($1.86 EPS), due to certain charges. Adjusted EPS was $1.67, down from $1.90 in the prior-year quarter. Reinforcement Materials segment EBIT decreased $31 million year-over-year, while Performance Chemicals EBIT increased $11 million. For the nine months ended June 30, 2026, revenue was $2.735 billion, down from $2.814 billion.

Strategy

Since early fiscal 2022, Cabot has pursued its 'Creating for Tomorrow' growth strategy, focusing on advantaged growth, innovative products, and continuous improvement. The company is investing in battery materials capacity in the U.S. and China to support electric vehicle demand. It also launched the EVOLVE Sustainable Solutions platform in fiscal 2023 to develop products using renewable or recovered materials and reduced-emission processes. Management emphasizes execution in dynamic market conditions and is expanding participation with global battery manufacturers.

Risks

  • Respirator liability reserves — Cabot maintains a significant reserve for respirator claims; future claims or legal outcomes could materially change the liability.
  • Reinforcement Materials pricing pressure — Lower gross profit per ton from calendar 2026 customer agreements and competitive intensity in Asia Pacific could continue to pressure segment EBIT.
  • Deferred tax asset realizability — Valuation allowances on deferred tax assets may be required if cumulative pre-tax losses occur in certain jurisdictions.
  • Restructuring and pension costs — Charges for restructuring actions and termination of U.K. pension plans impacted net income; further costs could arise.

Outlook

Management reaffirmed expectation of approximately $40 million EBITDA from battery materials for fiscal 2026. They continue to execute on capacity expansions and emphasize navigating market conditions. The leadership transition to Erica McLaughlin as President and CEO is effective October 1, 2026.

Recent SEC filings

40 most recent
Annual, quarterly & current reports